Reaction

Pulmonary Valve Sclerosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 12 reports · 3 co-occurring drugs

As of the last recalculation, Pulmonary Valve Sclerosis appears in 12 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RALTEGRAVIR (PRR 6,298.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Raltegravir106,298.06,301.8
Zidovudine94,666.64,669.8
Darunavir94,125.64,128.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.